Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 66938 [2013-26651]

Download as PDF 66938 Federal Register / Vol. 78, No. 216 / Thursday, November 7, 2013 / Notices (404)498–2506. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention tkelley on DSK3SPTVN1PROD with NOTICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Board of Scientific Counselors, Office of Public Health Preparedness and Response, Board of Scientific Counselors (BSC OPHPR) Notice of Cancellation: This notice concerns ‘‘Capacity Assistance for High Impact HIV Prevention’’, Funding Opportunity Announcement PS14– 1403, initial review, published in the Federal Register on September 18, 2013 (FR Volume 78, Number 181, Page 57391). This SEP, scheduled to convene on November 12–15, 2013, is canceled. Notice will be provided if the meeting is rescheduled in accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463). This notice is published less than the required 15 days prior to the start of the announced meeting, in accordance with Section 102–3.150(b) of the GSA Final Rule (2001) that allows for exceptions to the meeting notification time requirement. Section 102–3.150(b) states the following: ‘‘In exceptional circumstances, the agency or an independent Presidential advisory committee may give less than 15 calendar days’ notice, provided that the reasons for doing so are included in the advisory committee meeting notice published in the Federal Register.’’ In this case, the agency is giving less than 15 days’ notice due to the recent furlough status of United States Federal Government, including the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, from October 1–16, 2013. Contact Person for More Information: Harriette A. Lynch, Public Health Analyst, CDC, 1600 Clifton Road NE., Mailstop E07, Atlanta, Georgia 30333, Telephone: (404) 718–8837. The Director, Management Analysis and Services Office, has been delegated the Cancellation This notice was published in the Federal Register on September 12, 2013, Volume 78, Number 177, page 56235. The meeting previously scheduled to convene on October 16–17, 2013, was cancelled. Contact Person for More Information: Marquita Black, Executive Assistant, Office of Science and Public Health Practice, Centers for Disease Control and Prevention, 1600 Clifton Road, NE., Mailstop D–44, Atlanta, Georgia 30333, Telephone: (404) 639–7325; Facsimile: (404) 639–7977; Email: OPHPR.BSC.Questions@cdc.gov. This notice is published less than the required 15 days prior to the start of the announced meeting, in accordance with Section 102–3.150(b) of the GSA Final Rule (2001) that allows for exceptions to the meeting notification time requirement. Section 102–3.150(b) states the following: ‘‘In exceptional circumstances, the agency or an independent Presidential advisory committee may give less than 15 calendar days’ notice, provided that the reasons for doing so are included in the advisory committee meeting notice published in the Federal Register.’’ In this case, the agency is giving less than 15 days’ notice due to the recent furlough status of United States Federal Government, including the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, from October 1–16, 2013. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of Jkt 232001 [FR Doc. 2013–26634 Filed 11–6–13; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P BILLING CODE 4163–18–P 16:24 Nov 06, 2013 Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–26651 Filed 11–6–13; 8:45 am] [FR Doc. 2013–26636 Filed 11–6–13; 8:45 am] VerDate Mar<15>2010 meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention—State, Tribal, Local and Territorial (STLT) Subcommittee In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned subcommittee: Time and Date: 3:00 p.m.–4:10 p.m. EST, December 2, 2013. Place: This meeting will be held by teleconference. Status: This meeting is open to the public, limited only by the availability of telephone ports (100). The public is welcome to participate during the public comment period, which is tentatively scheduled from 4:00 p.m. to 4:05 p.m. To participate on the teleconference, please dial (888) 233–0592 and enter code 33288611. Purpose: The Subcommittee will provide advice to the CDC Director through the ACD on strategies and future needs and challenges faced by State, Tribal, Local and Territorial health agencies, and will provide guidance on opportunities for CDC. Matters To Be Discussed: The STLT Subcommittee members will discuss implementation of ACD-adopted recommendations related to the health department of the future and how CDC can best support STLT health departments. The agenda is subject to change as priorities dictate. Contact Person for More Information: Judy Monroe, M.D., Designated Federal Officer, STLT Territorial Subcommittee, ACD, CDC, 1600 Clifton Road, NE., M/S E–70, Atlanta, Georgia 30333. Telephone (404) 498–6775, Email: OSTLTSDirector@cdc.gov. Please submit comments to OSTLTSDirector@ cdc.gov by November 25, 2013. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and E:\FR\FM\07NON1.SGM 07NON1

Agencies

[Federal Register Volume 78, Number 216 (Thursday, November 7, 2013)]
[Notices]
[Page 66938]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-26651]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    Notice of Cancellation: This notice concerns ``Capacity Assistance 
for High Impact HIV Prevention'', Funding Opportunity Announcement 
PS14-1403, initial review, published in the Federal Register on 
September 18, 2013 (FR Volume 78, Number 181, Page 57391). This SEP, 
scheduled to convene on November 12-15, 2013, is canceled.
    Notice will be provided if the meeting is rescheduled in accordance 
with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 
92-463).
    This notice is published less than the required 15 days prior to 
the start of the announced meeting, in accordance with Section 102-
3.150(b) of the GSA Final Rule (2001) that allows for exceptions to the 
meeting notification time requirement. Section 102-3.150(b) states the 
following: ``In exceptional circumstances, the agency or an independent 
Presidential advisory committee may give less than 15 calendar days' 
notice, provided that the reasons for doing so are included in the 
advisory committee meeting notice published in the Federal Register.''
    In this case, the agency is giving less than 15 days' notice due to 
the recent furlough status of United States Federal Government, 
including the U.S. Department of Health and Human Services, Centers for 
Disease Control and Prevention, from October 1-16, 2013.
    Contact Person for More Information: Harriette A. Lynch, Public 
Health Analyst, CDC, 1600 Clifton Road NE., Mailstop E07, Atlanta, 
Georgia 30333, Telephone: (404) 718-8837. The Director, Management 
Analysis and Services Office, has been delegated the authority to sign 
Federal Register notices pertaining to announcements of meetings and 
other committee management activities, for both the Centers for Disease 
Control and Prevention and the Agency for Toxic Substances and Disease 
Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2013-26651 Filed 11-6-13; 8:45 am]
BILLING CODE 4163-18-P